New insider activity at Privia Health Group ( (PRVA) ) has taken place on March 13, 2025.
Key executives at Privia Health Group have recently sold significant amounts of company stock. EVP & CFO David Mountcastle sold 5,851 shares, totaling $141,658. EVP & GC Edward C Fargis sold 4,967 shares, amounting to $120,255. Meanwhile, CEO Parth Mehrotra sold 18,934 shares, with a total value of $458,409.
Recent Updates on PRVA stock
Privia Health Group has seen significant positive developments recently, with multiple firms raising their price targets for the company’s stock. Citizens JMP increased its target due to Privia’s strong Q4 performance, which exceeded expectations, and its strategic approach to risk management in value-based care. Piper Sandler also raised its target, citing Privia’s prudent contract management and strategic partnerships that have shielded it from the risks faced by others in the value-based care sector. Canaccord’s target increase was driven by the company’s effective business model execution and financial control. Privia’s Q4 earnings report highlighted strong financial metrics, including a 4.7% revenue increase and a 25.2% growth in adjusted EBITDA, alongside a robust cash position with no debt. The company’s strategic focus on value-based care and its expansion plans for 2025 further support its positive outlook.
More about Privia Health Group
YTD Price Performance: 22.00%
Average Trading Volume: 722,139
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.89B